Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Shaw

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2011
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker TeamStephen P Arnerić, Richard Batrla-Utermann, Laurel Beckett, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative DiseasesDiane Stephenson, Enrique Aviles, Lisa J Bain, et al.
Neuroimage|February 1, 2011
Characterizing Alzheimer's disease using a hypometabolic convergence indexKewei Chen, Napatkamon Ayutyanont, Jessica B S Langbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 13, 2013
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2014
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchSid E O'Bryant, Veer Gupta, Kim Henriksen, et al.
Annals of Neurology|December 1, 2023
Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White IndividualsSamuele Bonomi, Ruijin Lu, Suzanne E Schindler, et al.
Nature Medicine|April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degenerationMadison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 14, 2020
Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohortMelanie T Gentry, Maria I Lapid, Jeremy Syrjanen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia casesEliana Marisa Ramos, Deepika Reddy Dokuru, Victoria Van Berlo, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2011
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker TeamStephen P Arnerić, Richard Batrla-Utermann, Laurel Beckett, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative DiseasesDiane Stephenson, Enrique Aviles, Lisa J Bain, et al.
Neuroimage|February 1, 2011
Characterizing Alzheimer's disease using a hypometabolic convergence indexKewei Chen, Napatkamon Ayutyanont, Jessica B S Langbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 13, 2013
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2014
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchSid E O'Bryant, Veer Gupta, Kim Henriksen, et al.
Annals of Neurology|December 1, 2023
Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White IndividualsSamuele Bonomi, Ruijin Lu, Suzanne E Schindler, et al.
Nature Medicine|April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degenerationMadison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 14, 2020
Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohortMelanie T Gentry, Maria I Lapid, Jeremy Syrjanen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia casesEliana Marisa Ramos, Deepika Reddy Dokuru, Victoria Van Berlo, et al.
Pageof 6